Sema4

CM Life Sciences Inc (Nasdaq: CMLF) was a healthcare-focused special purpose acquisition company that completed a business combination with Sema4, a genomic information and health intelligence company, following a merger announcement in February 2021. CMLF completed its initial public offering in 2020, targeting opportunities at the intersection of life sciences, medtech, and data-driven medicine. Sema4, originally spun out of Mount Sinai Health System, operates a genomics and multimodal health data platform serving clinical and research customers. The transaction closed in 2021, with the combined company trading publicly under the Sema4 name. For comprehensive filing data, deal timelines, and institutional analytics on CMLF and the broader SPAC universe, sign up for full access on SpacDesk.

SPAC Counterparty (1)